14.0 References
1 Igea JM. The history of the idea of allergy. Allergy 2013;68 : 966–973.
2 Aldakheel FM. Allergic Diseases: A Comprehensive Review on Risk
Factors, Immunological Mechanisms, Link with COVID-19, Potential
Treatments, and Role of Allergen Bioinformatics. IJERPH 2021;18 : 12105.
3 Choi HW, Abraham SN. In Vitro and In Vivo IgE-/Antigen-Mediated Mast
Cell Activation. In: Reinhardt RL (ed). Type 2 Immunity . Springer
New York: New York, NY, 2018, pp 71–80.
4 Moote W, Kim H, Ellis AK. Allergen-specific immunotherapy.Allergy Asthma Clin Immunol 2018; 14 : 53.
5 Schoos A-MM, Bullens D, Chawes BL, Costa J, De Vlieger L, DunnGalvin Aet al. Immunological Outcomes of Allergen-Specific Immunotherapy
in Food Allergy. Front Immunol 2020; 11 : 568598.
6 Kanagaratham C, El Ansari YS, Lewis OL, Oettgen HC. IgE and IgG
Antibodies as Regulators of Mast Cell and Basophil Functions in Food
Allergy. Front Immunol 2020; 11 : 603050.
7 Wang N, Wang J, Zhang Y, Zeng Y, Hu S, Bai H et al. Imperatorin
ameliorates mast cell-mediated allergic airway inflammation by
inhibiting MRGPRX2 and CamKII/ERK signaling pathway. Biochemical
Pharmacology 2021; 184 : 114401.
8 Brown JM, Wilson TM, Metcalfe DD. The mast cell and allergic diseases:
role in pathogenesis and implications for therapy. Clin
Experimental Allergy 2008; 38 : 4–18.
9 Hermans MAW, Van Stigt AC, Van De Meerendonk S, Schrijver B, Van Daele
PLA, Van Hagen PM et al. Human Mast Cell Line HMC1 Expresses
Functional Mas-Related G-Protein Coupled Receptor 2. Front
Immunol 2021; 12 : 625284.
10 L’homme L, Dombrowicz D. In vitro models of human mast cells: How to
get more and better with induced pluripotent stem cells? Journal
of Allergy and Clinical Immunology 2022; 149 : 904–906.
11 Huang J, Liu C, Wang Y, Wang C, Xie M, Qian Y et al.Application of in vitro and in vivo models in the study of food allergy.Food Science and Human Wellness 2018; 7 : 235–243.
12 Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an
immature mast cell line from a patient with mast cell leukemia.Leukemia Research 1988; 12 : 345–355.
13 Valent P, Bettelheim P. Cell Surface Structures on Human Basophils
and Mast Cells: Biochemical and Functional Characterization. In:Advances in Immunology . Elsevier, 1992, pp 333–423.
14 Nilsson G, Blom T, Kusche‐Gullberg M, Kjellen L, Butterfield JH,
Sundström C et al. Phenotypic Characterization of the Human
Mast‐Cell Line HMC‐1. Scand J Immunol 1994; 39 :
489–498.
15 Sundström M, Vliagoftis H, Karlberg P, Butterfield JH, Nilsson K,
Metcalfe DD et al. Functional and phenotypic studies of two
variants of a human mast cell line with a distinct set of mutations in
the c‐kit proto‐oncogene. Immunology 2003; 108 :
89–97.
16 Tobío A, Alfonso A, Botana LM. Cross-talks between c-Kit and PKC
isoforms in HMC-1560 and HMC-1560,816 cells. Different role of PKCδ in
each cellular line. Cellular Immunology 2015; 293 :
104–112.
17 Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu Uet al. Identification of mutations in the coding sequence of the
proto-oncogene c-kit in a human mast cell leukemia cell line causing
ligand-independent activation of c-kit product. J Clin Invest1993; 92 : 1736–1744.
18 Da Silva CA, Reber L, Frossard N. Stem cell factor expression, mast
cells and inflammation in asthma. Fundamemntal Clinical Pharma2006; 20 : 21–39.
19 Rådinger M, Jensen BM, Kuehn HS, Kirshenbaum A, Gilfillan AM.
Generation, Isolation, and Maintenance of Human Mast Cells and Mast Cell
Lines Derived from Peripheral Blood or Cord Blood. CP in
Immunology 2010; 90 . doi:10.1002/0471142735.im0737s90.
20 Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JHet al. The c-KIT mutation causing human mastocytosis is resistant
to STI571 and other KIT kinase inhibitors; kinases with enzymatic site
mutations show different inhibitor sensitivity profiles than wild-type
kinases and those with regulatory-type mutations. Blood 2002;99 : 1741–1744.
21 Sun J, Pedersen M, Rönnstrand L. The D816V Mutation of c-Kit
Circumvents a Requirement for Src Family Kinases in c-Kit Signal
Transduction. Journal of Biological Chemistry 2009; 284 :
11039–11047.
22 Guhl S, Babina M, Neou A, Zuberbier T, Artuc M. Mast cell lines HMC‐1
and LAD2 in comparison with mature human skin mast cells – drastically
reduced levels of tryptase and chymase in mast cell lines.Experimental Dermatology 2010; 19 : 845–847.
23 Krystel-Whittemore M, Dileepan KN, Wood JG. Mast Cell: A
Multi-Functional Master Cell. Front Immunol 2016; 6 .
doi:10.3389/fimmu.2015.00620.
24 Lee M, Lee NY, Chung K-S, Cheon S-Y, Lee K-T, An H-J. Roxatidine
attenuates mast cell-mediated allergic inflammation via inhibition of
NF-κB and p38 MAPK activation. Sci Rep 2017; 7 : 41721.
25 Wu X, Lin M, Li Y, Zhao X, Yan F. Effects of DMEM and RPMI 1640 on
the biological behavior of dog periosteum-derived cells.Cytotechnology 2009; 59 : 103–111.
26 Huang Z, Shao W, Gu J, Hu X, Shi Y, Xu W et al. Effects of
culture media on metabolic profiling of the human gastric cancer cell
line SGC7901. Mol BioSyst 2015; 11 : 1832–1840.
27 Liu YK, Lu QZ, Pei R, Ji HJ, Zhou GS, Zhao XL et al. The
effect of extracellular calcium and inorganic phosphate on the growth
and osteogenic differentiation of mesenchymal stem cells in
vitro : implication for bone tissue engineering. Biomed Mater2009; 4 : 025004.
28 Afzan MY, Mohammed AJ. Role of L-glutamine in the in-vitro growth of
HCT-8 and HT-29 cell lines. Mal J Anim 2019; 23 :
580–585.
29 Jagušić M, Forčić D, Brgles M, Kutle L, Šantak M, Jergović M et
al. Stability of Minimum Essential Medium functionality despite
l-glutamine decomposition. Cytotechnology 2016; 68 :
1171–1183.
30 Coëffier M, Miralles-Barrachina O, Le Pessot F, Lalaude O, Daveau M,
Lavoinne A et al. INFLUENCE OF GLUTAMINE ON CYTOKINE PRODUCTION
BY HUMAN GUT IN VITRO. Cytokine 2001; 13 : 148–154.
31 Lechowski S, Feilhauer K, Staib L, Coëffier M, Bischoff SC, Lorentz
A. Combined arginine and glutamine decrease release of de novo
synthesized leukotrienes and expression of proinflammatory cytokines in
activated human intestinal mast cells. Eur J Nutr 2013;52 : 505–512.
32 Wang X, Huang L, Qu Y, Lv H, He X. Effects of glutamine on cytokines
1L‑1 and TNF‑α in rehabilitation and prognosis of patients with
lobectomy. Exp Ther Med 2018. doi:10.3892/etm.2018.6443.
33 Horio Y, Osawa S, Takagaki K, Hishida A, Furuta T, Ikuma M. Glutamine
supplementation increases Th1-cytokine responses in murine intestinal
intraepithelial lymphocytes. Cytokine 2008; 44 : 92–95.
34 Abusalamah H, Reel JM, Lupfer CR. Pyruvate affects inflammatory
responses of macrophages during influenza A virus infection. Virus
Research 2020; 286 : 198088.
35 Nitta N, Aoki Y, Isogawa Y, Tsuchiya T, Kanegasaki S. Image analysis
of mast cell degranulation in a concentration gradient of stimuli formed
in the channel between a glass plate and a silicon substrate.European Journal of Cell Biology 2009; 88 : 541–549.
36 Chelombitko MA, Firsov AM, Kotova EA, Rokitskaya TI, Khailova LS,
Popova LB et al. Usnic acid as calcium ionophore and mast cells
stimulator. Biochimica et Biophysica Acta (BBA) - Biomembranes2020; 1862 : 183303.
37 Pi J, Huang L, Yang F, Jiang J, Jin H, Liu J et al. Atomic
force microscopy study of ionomycin‐induced degranulation in RBL‐2H3
cells. Scanning 2016; 38 : 525–534.
38 Chang SN, Dey DK, Oh ST, Kong WH, Cho KH, Al-Olayan EM et al.Phorbol 12-Myristate 13-Acetate Induced Toxicity Study and the Role of
Tangeretin in Abrogating HIF-1α-NF-κB Crosstalk In Vitro and In Vivo.IJMS 2020; 21 : 9261.
39 Keski-Nisula L, Roponen M, Hirvonen M-R, Heinonen S, Pekkanen J.
Stimulated cytokine production correlates in umbilical arterial and
venous blood at delivery. Eur Cytokine Netw 2004; 15 :
347–352.
40 Barten MJ, Rahmel A, Bocsi J, Boldt A, Garbade J, Dhein S et
al. Cytokine analysis to predict immunosuppression. Cytometry Pt
A 2006; 69A : 155–157.
41 Olsen I, Sollid LM. Pitfalls in determining the cytokine profile of
human T cells. Journal of Immunological Methods 2013;390 : 106–112.
42 Zimmermann J, Radbruch A, Chang H. A Ca 2+concentration of 1.5 mM, as present in IMDM but not in RPMI, is critical
for maximal response of Th cells to PMA/ionomycin. Eur J Immunol2015; 45 : 1270–1273.
43 Ai W, Li H, Song N, Li L, Chen H. Optimal Method to Stimulate
Cytokine Production and Its Use in Immunotoxicity Assessment.IJERPH 2013; 10 : 3834–3842.
44 Schemann M, Kugler EM, Buhner S, Eastwood C, Donovan J, Jiang Wet al. The Mast Cell Degranulator Compound 48/80 Directly
Activates Neurons. PLoS ONE 2012; 7 : e52104.
45 Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA et
al. Characterization of novel stem cell factor responsive human mast
cell lines LAD 1 and 2 established from a patient with mast cell
sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI.Leukemia Research 2003; 27 : 677–682.
46 Kirshenbaum AS, Yin Y, Sundstrom JB, Bandara G, D. Metcalfe D.
Description and Characterization of a Novel Human Mast Cell Line for
Scientific Study. IJMS 2019; 20 : 5520.
47 Kirshenbaum AS, Petrik A, Walsh R, Kirby TL, Vepa S, Wangsa Det al. A Ten-Year Retrospective Analysis of the Distribution, Use
and Phenotypic Characteristics of the LAD2 Human Mast Cell Line.Int Arch Allergy Immunol 2014; 164 : 265–270.
48 Ohta Y, Yashiro K, Ohashi K, Horikoshi Y, Kusumoto C, Matsura T.
Compound 48/80, a mast cell degranulator, causes oxidative damage by
enhancing vitamin C synthesis via reduced glutathione depletion and
lipid peroxidation through neutrophil infiltration in rat livers.J Clin Biochem Nutr 2017; 60 : 187–198.
49 Che D, Zheng Y, Hou Y, Du X, Jia T, Zhao Q et al. Action of
substance P and PAMP(9-20) on different excitation sites of MRGPRX2
induces differences in mast cell activation. International
Immunopharmacology 2021; 101 : 108342.
50 Wolf K, Kühn H, Boehm F, Gebhardt L, Glaudo M, Agelopoulos K et
al. A group of cationic amphiphilic drugs activates MRGPRX2 and induces
scratching behavior in mice. Journal of Allergy and Clinical
Immunology 2021; 148 : 506-522.e8.
51 Che D, Gao J, Du X, Zheng Y, Hou Y, Peng B et al.p-Phenylenediamine induces immediate contact allergy and
non-histaminergic itch via MRGPRX2. Chemico-Biological
Interactions 2022; 351 : 109751.
52 Duraisamy K, Singh K, Kumar M, Lefranc B, Bonnafé E, Treilhou Met al. P17 induces chemotaxis and differentiation of monocytes
via MRGPRX2-mediated mast cell–line activation. Journal of
Allergy and Clinical Immunology 2022; 149 : 275–291.
53 Choi HW, Chan C, Shterev ID, Lynch HE, Robinette TJ, Johnson-Weaver
BT et al. Identification of Novel Mast Cell Activators Using
Cell-Based High-Throughput Screening. SLAS Discovery 2019;24 : 628–640.
54 Ng K, Raheem J, St Laurent CD, Marcet CT, Vliagoftis H, Befus ADet al. Responses of human mast cells and epithelial cells
following exposure to influenza A virus. Antiviral Research 2019;171 : 104566.
55 Lian Q, Cheng Y, Zhong C, Wang F. Inhibition of the IgE-Mediated
Activation of RBL-2H3 Cells by TIPP, a Novel Thymic Immunosuppressive
Pentapeptide. IJMS 2015; 16 : 2252–2268.
56 Lee B-C, Kim J-J, Lee JY, Kang I, Shin N, Lee S-E et al.Disease-specific primed human adult stem cells effectively ameliorate
experimental atopic dermatitis in mice. Theranostics 2019;9 : 3608–3621.
57 Park YH, Kim DK, Kim HS, Lee D, Lee MB, Min KY et al. WZ3146
inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses
in vitro and in vivo. Toxicology and Applied Pharmacology 2019;383 : 114763.
58 Sun M, Qin D, Fan P, Chen X, Liu Y. Chitosan-centered nanosystems as
sustained therapeutics for allergic rhinitis intervention: Inhibition of
histamine-induced cascades. Journal of Controlled Release 2021;335 : 422–436.
59 Falcone FH, Wan D, Barwary N, Sagi‐Eisenberg R. RBL cells as
models for in vitro studies of mast cells and basophils.Immunological Reviews 2018; 282 : 47–57.
60 Eccleston E, Leonard BJ, Lowe JS, Welford HJ. Basophilic Leukaemia in
the Albino Rat and a Demonstration of the Basopoietin. Nature New
Biology 1973; 244 : 73–76.
61 Kulczycki A, Metzger H. The Interaction of IgE with Rat Basophilic
Leukemia Cells. The Journal of Experimental Medicine 1974;140 : 1676–1695.
62 Kulczycki A, Isersky C, Metzger H. The Interaction of IgE with Rat
Basophilic Leukemia Cells. The Journal of Experimental Medicine1974; 139 : 600–616.
63 Siraganian RP, Kulczycki A, Mendoza G, Metzger H. Ionophore A-23187
Induced Histamine Release from Rat Mast Cells and Rat Basophil Leukemia
(RBL-1) Cells. The Journal of Immunology 1975; 115 :
1599–1602.
64 Barsumian EL, Isersky C, Petrino MG, Siraganian RP. IgE‐induced
histamine release from rat basophilic leukemia cell lines: isolation of
releasing and nonreleasing clones. Eur J Immunol 1981;11 : 317–323.
65 Carson DA, Kulczycki A, Metzger H. Interaction of IgE with Rat
Basophilic Leukemia Cells. The Journal of Immunology 1975;114 : 158–160.
66 Passante E, Frankish N. The RBL-2H3 cell line: its provenance and
suitability as a model for the mast cell. Inflamm Res 2009;58 : 737–745.
67 Passante E, Ehrhardt C, Sheridan H, Frankish N. RBL-2H3 cells are an
imprecise model for mast cell mediator release. Inflamm Res 2009;58 : 611–618.
68 Mazurek N, Bashkin P, Petrank A, Pecht I. Basophil variants with
impaired cromoglycate binding do not respond to an immunological
degranulation stimulus. Nature 1983; 303 : 528–530.
69 Gibbs BF, Amon FL, Pearce U. Spontaneous histamine release from mast
cells and basophils is controlled by the cellular environment.Inflammation Research 1997; 46 : 25–26.
70 Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF. Differentiation
in vitro of hybrid eosinophil/basophil granulocytes: autocrine function
of an eosinophil developmental intermediate. The Journal of
experimental medicine 1995; 182 : 49–57.
71 Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD.
Demonstration That Human Mast Cells Arise From a Progenitor Cell
Population That Is CD34+, c-kit+, and Expresses Aminopeptidase N (CD13).Blood 1999; 94 : 2333–2342.
72 Denburg J. Basophil and mast cell lineages in vitro and in vivo
[published erratum appears in Blood 1992 Aug 1;80(3):855].Blood 1992; 79 : 846–860.
73 Li L, Li Y, Reddel SW, Cherrian M, Friend DS, Stevens RL et
al. Identification of basophilic cells that express mast cell granule
proteases in the peripheral blood of asthma, allergy, and drug-reactive
patients. J Immunol 1998; 161 : 5079–5086.
74 Maeyama K, Hohman RJ, Metzger H, Beaven MA. Quantitative
relationships between aggregation of IgE receptors, generation of
intracellular signals, and histamine secretion in rat basophilic
leukemia (2H3) cells. Enhanced responses with heavy water. J Biol
Chem 1986; 261 : 2583–2592.
75 Seldin DC, Adelman S, Austen KF, Stevens RL, Hein A, Caulfield JPet al. Homology of the rat basophilic leukemia cell and the rat
mucosal mast cell. Proc Natl Acad Sci USA 1985; 82 :
3871–3875.
76 Tsujimura T, Furitsu T, Morimoto M, Kanayama Y, Nomura S, Matsuzawa Yet al. Substitution of an Aspartic Acid Results in Constitutive
Activation of c-kit Receptor Tyrosine Kinase in a Rat Tumor Mast
Cell Line RBL-2H3. Int Arch Allergy Immunol 1995; 106 :
377–385.
77 Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell
activation. Nat Rev Immunol 2006; 6 : 218–230.
78 Coleman JW. A kinetic analysis of the in vitro sensitization of
murine peritoneal mast cells with monoclonal IgE anti-DNP antibody.Immunology 1988; 64 : 527–531.
79 Dearman R, Skinner R, Deakin N, Shaw D, Kimber I. Evaluation of an in
vitro method for the measurement of specific IgE antibody responses: the
rat basophilic leukemia (RBL) cell assay. Toxicology 2005;206 : 195–205.
80 Moon TC, Befus AD, Kulka M. Mast Cell Mediators: Their Differential
Release and the Secretory Pathways Involved. Front Immunol 2014;5 . doi:10.3389/fimmu.2014.00569.
81 Dedkova EN, Sigova AA, Zinchenko VP. Mechanism of action of calcium
ionophores on intact cells: ionophore-resistant cells. Membr Cell
Biol 2000; 13 : 357–368.
82 Johnson HG, Bach MK. Prevention of Calcium Ionophore-Induced Release
of Histamine in Rat Mast Cells by Disodium Cromoglycate. The
Journal of Immunology 1975; 114 : 514–516.
83 Ludowyke RI, Scurr LL, McNally CM. Calcium ionophore-induced
secretion from mast cells correlates with myosin light chain
phosphorylation by protein kinase C. The Journal of Immunology1996; 157 : 5130–5138.
84 Mousli M, Bueb J-L, Bronner C, Rouot B, Landry Y. G protein
activation: a receptor-independent mode of action for cationic
amphiphilic neuropeptides and venom peptides. Trends in
Pharmacological Sciences 1990; 11 : 358–362.
85 Tomita U, Inanobe A, Kobayashi I, Takahashi K, Ui M, Katada T. Direct
Interactions of Mastoparan and Compound 48/80 with GTP-Binding
Proteins1. The Journal of Biochemistry 1991; 109 :
184–189.
86 Tanaka T, Kohno T, Kinoshita S, Mukai H, Itoh H, Ohya M et al.α Helix Content of G Protein α Subunit Is Decreased upon Activation by
Receptor Mimetics. Journal of Biological Chemistry 1998;273 : 3247–3252.
87 Senyshyn J, Baumgartner RA, Beaven MA. Quercetin Sensitizes RBL-2H3
Cells to Polybasic Mast Cell Secretagogues Through Increased Expression
of Gi GTP-Binding Proteins Linked to a Phospholipase C Signaling
Pathway. The Journal of Immunology 1998; 160 :
5136–5144.
88 Chahdi A, Fraundorfer PF, Beaven MA. Compound 48/80 activates mast
cell phospholipase D via heterotrimeric GTP-binding proteins. J
Pharmacol Exp Ther 2000; 292 : 122–130.
89 Swieter M, Midura RJ, Nishikata H, Oliver C, Berenstein EH,
Mergenhagen SE et al. Mouse 3T3 fibroblasts induce rat basophilic
leukemia (RBL-2H3) cells to acquire responsiveness to compound 48/80.The Journal of Immunology 1993; 150 : 617–624.
90 Hasala H, Giembycz MA, Janka-Junttila M, Moilanen E, Kankaanranta H.
Histamine reverses IL-5-afforded human eosinophil survival by inducing
apoptosis: Pharmacological evidence for a novel mechanism of action of
histamine. Pulmonary Pharmacology & Therapeutics 2008;21 : 222–233.
91 Nakatani K, Atsumi M, Arakawa T, Oosawa K, Shimura S, Nakahata Net al. Inhibitions of Histamine Release and Prostaglandin E2
Synthesis by Mangosteen, a Thai Medicinal Plant. Biological &
Pharmaceutical Bulletin 2002; 25 : 1137–1141.
92 Kobayashi M, Matsushita H, Yoshida K, Tsukiyama R-I, Sugimura T,
Yamamoto K. In vitro and in vivo anti-allergic activity of soy sauce.Int J Mol Med 2004. doi:10.3892/ijmm.14.5.879.
93 Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol2004; 4 : 787–799.
94 Gon Y, Nunomura S, Ra C. Common and distinct signalling cascades in
the production of tumour necrosis factor‐α and interleukin‐13 induced by
lipopolysaccharide in RBL‐2H3 cells. Clin Experimental Allergy2005; 35 : 635–642.
95 Conrad DH, Wingard JR, Ishizaka T. The interaction of human and
rodent IgE with the human basophil IgE receptor. The Journal of
Immunology 1983; 130 : 327–333.
96 Hakimi J, Seals C, Kondas JA, Pettine L, Danho W, Kochan J. The alpha
subunit of the human IgE receptor (FcERI) is sufficient for high
affinity IgE binding. J Biol Chem 1990; 265 :
22079–22081.
97 Gilfillan AM, Kado-Fong H, Wiggan GA, Hakimi J, Kent U, Kochan JP.
Conservation of signal transduction mechanisms via the human Fc epsilon
RI alpha after transfection into a rat mast cell line, RBL 2H3. J
Immunol 1992; 149 : 2445–2451.
98 Taudou G, Varin-Blank N, Jouin H, Marchand F, Weyer A, Blank U.
Expression of the Alpha Chain of Human FcεRI in Transfected Rat
Basophilic Leukemia Cells: Functional Activation after Sensitization
with Human Mite-Specific IgE. Int Arch Allergy Immunol 1993;100 : 344–350.
99 Wilson APM, Pullar CE, Camp AM, Helm BA. Human IgE mediates stimulus
secretion coupling in rat basophilic leukemia cells transfected with the
α chain of the human high‐affinity receptor. Eur J Immunol 1993;23 : 240–244.
100 Vogel L, Lüttkopf D, Hatahet L, Haustein D, Vieths S. Development of
a functional in vitro assay as a novel tool for the
standardization of allergen extracts in the human system. Allergy2005; 60 : 1021–1028.
101 Lowe J, Jardieu P, VanGorp K, Fei DTW. Allergen-induced histamine
release in rat mast cells transfected with the α subunits of FcεRI.Journal of Immunological Methods 1995; 184 : 113–122.
102 Ladics GS, Van Bilsen JHM, Brouwer HMH, Vogel L, Vieths S, Knippels
LMJ. Assessment of three human FcεRI-transfected RBL cell-lines for
identifying IgE induced degranulation utilizing peanut-allergic patient
sera and peanut protein extract. Regulatory Toxicology and
Pharmacology 2008; 51 : 288–294.
103 Blanc F, Adel‐Patient K, Drumare M ‐F., Paty E, Wal J ‐M., Bernard
H. Capacity of purified peanut allergens to induce degranulation in a
functional in vitro assay: Ara h 2 and Ara h 6 are the most
efficient elicitors. Clin Experimental Allergy 2009; 39 :
1277–1285.
104 Sun N, Zhou C, Zhou X, Sun L, Che H. Use of a rat basophil leukemia
(RBL) cell-based immunological assay for allergen identification,
clinical diagnosis of allergy, and identification of anti-allergy agents
for use in immunotherapy. Journal of Immunotoxicology 2015;12 : 199–205.
105 Wiegand TW, Williams PB, Dreskin SC, Jouvin MH, Kinet JP, Tasset D.
High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc
epsilon receptor I. The Journal of Immunology 1996; 157 :
221–230.
106 Nakamura R, Uchida Y, Higuchi M, Nakamura R, Tsuge I, Urisu Aet al. A convenient and sensitive allergy test: IgE
crosslinking‐induced luciferase expression in cultured mast cells.Allergy 2010; 65 : 1266–1273.
107 Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by
calcium, calcineurin, and NFAT. Genes Dev 2003; 17 :
2205–2232.
108 Wan D, Wang X, Nakamura R, Alcocer MJC, Falcone FH. Use of Humanized
RBL Reporter Systems for the Detection of Allergen-Specific IgE
Sensitization in Human Serum. In: Gibbs BF, Falcone FH (eds).Basophils and Mast Cells . Springer US: New York, NY, 2020, pp
145–153.
109 Wan D, Ludolf F, Alanine DGW, Stretton O, Ali Ali E, Al-Barwary Net al. Use of Humanised Rat Basophilic Leukaemia Cell Line
RS-ATL8 for the Assessment of Allergenicity of Schistosoma mansoni
Proteins. PLoS Negl Trop Dis 2014; 8 : e3124.
110 Falcone FH, Alcocer MJC, Okamoto-Uchida Y, Nakamura R. Use of
Humanized Rat Basophilic Leukemia Reporter Cell Lines as a Diagnostic
Tool for Detection of Allergen-Specific IgE in Allergic Patients: Time
for a Reappraisal? Curr Allergy Asthma Rep 2015; 15 : 67.
111 Lupi R, Denery-Papini S, Claude M, Tranquet O, Drouet M, Masci Set al. Thermal treatment reduces gliadin recognition by IgE, but
a subsequent digestion and epithelial crossing permits recovery.Food Research International 2019; 118 : 22–31.
112 Hazebrouck S, Patil SU, Guillon B, Lahood N, Dreskin SC,
Adel-Patient K et al. Immunodominant conformational and linear
IgE epitopes lie in a single segment of Ara h 2. Journal of
Allergy and Clinical Immunology 2022; 150 : 131–139.
113 Villazala-Merino S, Rodriguez-Dominguez A, Stanek V, Campion NJ,
Gattinger P, Hofer G et al. Allergen-specific IgE levels and the
ability of IgE-allergen complexes to cross-link determine the extent of
CD23-mediated T-cell activation. Journal of Allergy and Clinical
Immunology 2020; 145 : 958-967.e5.
114 Laidlaw TM, Steinke JW, Tiñana AM, Feng C, Xing W, Lam BK et
al. Characterization of a novel human mast cell line that responds to
stem cell factor and expresses functional FcεRI. Journal of
Allergy and Clinical Immunology 2011; 127 : 815-822.e5.
115 Saleh R, Wedeh G, Herrmann H, Bibi S, Cerny-Reiterer S, Sadovnik Iet al. A new human mast cell line expressing a functional IgE
receptor converts to tumorigenic growth by KIT D816V transfection.Blood 2014; 124 : 111–120.
116 Galli SJ, Dvorak AM, Marcum JA, Ishizaka T, Nabel G, Der Simonian Het al. Mast cell clones: a model for the analysis of cellular
maturation. The Journal of cell biology 1982; 95 :
435–444.
117 Staats HF, Kirwan SM, Choi HW, Shelburne CP, Abraham SN, Leung GYCet al. A mast cell degranulation screening assay for the
identification of novel mast cell activating agents. Med Chem
Commun 2013; 4 : 88–94.
118 Jin S, Ha H, Shin H-K, Seo C-S. Anti-Allergic and Anti-Inflammatory
Effects of Kuwanon G and Morusin on MC/9 Mast Cells and HaCaT
Keratinocytes. Molecules 2019; 24 : 265.
119 Gajewski TF, Markiewicz MA, Uyttenhove C. The P815 Mastocytoma Tumor
Model. CP in Immunology 2001; 43 .
doi:10.1002/0471142735.im2004s43.
120 Terrén I, Astarloa-Pando G, Amarilla-Irusta A, Borrego F. P815-based
redirected degranulation assay to study human NK cell effector
functions. In: Methods in Cell Biology . Elsevier, 2023, pp
33–48.
121 Chen B-R, Hsu K-T, Hsu W-H, Lee B-H, Li T-L, Chan Y-L et al.Immunomodulation and mechanisms of fucoidan from Cladosiphon okamuranus
ameliorates atopic dermatitis symptoms. International Journal of
Biological Macromolecules 2021; 189 : 537–543.
122 Blank U, Falcone FH, Nilsson G. The history of mast cell and
basophil research – some lessons learnt from the last century.Allergy 2013; 68 : 1093–1101.